During an online Capital Market Day, Wacker Chemie AG today presented its new sustainable development goals to investors and analysts. WACKER’s new goals are much more ambitious than its previous ones.
Due to the ongoing corona pandemic, Wacker Chemie AG has decided to hold next year’s Annual Shareholders’ Meeting scheduled for May 20, 2022, as a virtual event without the physical presence of its shareholders or their proxies.
Wacker Chemie AG ended Q3 2021 with strong growth in sales and earnings thanks to continued high customer demand across all business divisions.
The Munich-based chemical company WACKER acquires a 60 percent stake in specialty silane manufacturer SICO Performance Material Co., Ltd, Jining (China).
Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, and Wacker Biotech announced today that they had signed a contract for the manufacturing of Prokarium’s microbial novel immunotherapy for bladder cancer.